Detalhe da pesquisa
1.
Pre-encoded responsiveness to type I interferon in the peripheral immune system defines outcome of PD1 blockade therapy.
Nat Immunol
; 23(8): 1273-1283, 2022 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-35835962
2.
ARIH2 is essential for embryogenesis, and its hematopoietic deficiency causes lethal activation of the immune system.
Nat Immunol
; 14(1): 27-33, 2013 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-23179078
3.
Reprogramming T-cell metabolism to enhance adoptive cell therapies.
Int Immunol
; 36(6): 261-278, 2024 Apr 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-38364321
4.
Phase II clinical trial of adoptive cell therapy for patients with metastatic melanoma with autologous tumor-infiltrating lymphocytes and low-dose interleukin-2.
Cancer Immunol Immunother
; 68(5): 773-785, 2019 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-30747243
5.
Glycogen Synthase Kinase-3 Modulates Cbl-b and Constrains T Cell Activation.
J Immunol
; 199(12): 4056-4065, 2017 12 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-29109121
6.
Immune checkpoint inhibitors in cancer immunotherapy.
CMAJ
; 192(24): E651, 2020 06 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-32540906
7.
Characterization of innate lymphoid cell subsets infiltrating melanoma and epithelial ovarian tumors.
Oncoimmunology
; 13(1): 2349347, 2024.
Artigo
em Inglês
| MEDLINE | ID: mdl-38746870
8.
Ex vivo activation of the GCN2 pathway metabolically reprograms T cells, leading to enhanced adoptive cell therapy.
Cell Rep Med
; 5(3): 101465, 2024 Mar 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-38460518
9.
Analysis of the Circulating Metabolome of Patients with Cutaneous, Mucosal and Uveal Melanoma Reveals Distinct Metabolic Profiles with Implications for Response to Immunotherapy.
Cancers (Basel)
; 15(14)2023 Jul 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-37509369
10.
Immune Checkpoint Inhibitors in Advanced Cutaneous Squamous Cell Carcinoma: Real-World Experience from a Canadian Comprehensive Cancer Centre.
Cancers (Basel)
; 15(17)2023 Aug 29.
Artigo
em Inglês
| MEDLINE | ID: mdl-37686588
11.
The Role of Adjuvant Radiotherapy for the Treatment of Resected High-Risk Stage III Cutaneous Melanoma in the Era of Modern Systemic Therapies.
Cancers (Basel)
; 15(24)2023 Dec 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-38136412
12.
Turnaround Times in Melanoma BRAF Testing and the Impact on the Initiation of Systemic Therapy at a Single Tertiary Care Cancer Center.
JCO Oncol Pract
; 18(5): e642-e647, 2022 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-35363503
13.
c-Rel phenocopies PKCtheta but not Bcl-10 in regulating CD8+ T-cell activation versus tolerance.
Eur J Immunol
; 40(3): 867-77, 2010 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-19950170
14.
Presumed complement-mediated, checkpoint inhibitor-induced, thrombotic microangiopathy in a patient with metastatic melanoma.
BMJ Case Rep
; 14(7)2021 Jul 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-34312126
15.
Biologic subtypes of melanoma predict survival benefit of combination anti-PD1+anti-CTLA4 immune checkpoint inhibitors versus anti-PD1 monotherapy.
J Immunother Cancer
; 9(1)2021 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-33483342
16.
CANDIED: A Pan-Canadian Cohort of Immune Checkpoint Inhibitor-Induced Insulin-Dependent Diabetes Mellitus.
Cancers (Basel)
; 14(1)2021 Dec 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-35008256
17.
Development of a Metastatic Uveal Melanoma Prognostic Score (MUMPS) for Use in Patients Receiving Immune Checkpoint Inhibitors.
Cancers (Basel)
; 13(14)2021 Jul 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-34298857
18.
Coenzyme A fuels T cell anti-tumor immunity.
Cell Metab
; 33(12): 2415-2427.e6, 2021 12 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-34879240
19.
Clinical impact of COVID-19 on patients with cancer treated with immune checkpoint inhibition.
J Immunother Cancer
; 9(1)2021 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-33468556
20.
The sound of silence: modulating anergy in T lymphocytes.
Curr Opin Immunol
; 19(6): 658-64, 2007 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-17949964